Sjögren’s Disease

The ACR: Looking Ahead to 2015 and Beyond

E. William St.Clair, MD | December 1, 2014

Incoming president E. William St.Clair, MD, sets goals, reviews groundwork for the coming year

Pilar Brito-Zerón, MD, PhD, and Manuel Ramos-Casals, MD, PhD, on behalf of the EULAR-SS Task Force Group | November 1, 2014

Differences in its epidemiologic, clinical and immunologic features underscore need for a homogeneous diagnostic and therapeutic approach

Thomas R. Collins | September 1, 2014

Experts offer insight into ultrasound for joint counts in rheumatoid arthritis, synovial biopsies, Sjögren’s syndrome

David C. Holzman | July 1, 2014

By asking about their sexual relationships, rheumatologists can improve quality of patients’ love lives

Careful collaboration is key to treating patients with rheumatic or inflammatory diseases that affect the eyes

Sarah Schafer, MD | November 1, 2013

A physician–patient’s experience with Sjögren’s syndrome

Robert I. Fox, MD, PhD, and Carla M. Fox, RN | November 1, 2013

Beyond biologic agents, scientists study cytokines, chemokines, and the interface between inflammatory and neural/secretory pathways

Sarah Schafer, MD | September 10, 2013

A physician–patient’s experience with Sjögren’s syndrome

Research has led to greater understanding of the disease, potential for better treatment options

Emine Atac, MD, and John H. Stone, MD, MPH | January 1, 2013

What rheumatologists need to know about identifying and diagnosing immunoglobulin G4-related disease (IgG4-RD)